Finance

Lists
2652:HKG
CF PharmTech Inc
5,98 HK$
+1,18%
(+0,070) 1D
16 қаз., 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2652...
Open
6,15 HK$
High
6,15 HK$
Low
5,77 HK$
Mkt. cap
2,58 млрд
Avg. vol.
3,50 млн
Volume
1,96 млн
52-wk high
39,50 HK$
52-wk low
5,18 HK$
Shares outstanding
323,97 млн
No. of employees
625
Open
6,15 HK$
High
6,15 HK$
Low
5,77 HK$
Mkt. cap
2,58 млрд
Avg. vol.
3,50 млн
Volume
1,96 млн
52-wk high
39,50 HK$
52-wk low
5,18 HK$
Shares outstanding
323,97 млн
No. of employees
625
News stories
From web sources and news partners
About CF PharmTech Inc
CEO-
Employees625
Founded2007
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. нау.
2025 ж. мау.
2026 ж. нау.
2026 ж. мау.
Revenue
135,94 млн
69,94 млн
105,08 млн
105,08 млн
Cost of goods sold
28,28 млн
21,05 млн
24,33 млн
24,33 млн
Cost of revenue
28,28 млн
21,05 млн
24,33 млн
24,33 млн
Research and development expenses
32,34 млн
28,46 млн
30,34 млн
30,34 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
65,66 млн
41,20 млн
49,55 млн
49,55 млн
Operating expense
99,07 млн
69,94 млн
81,07 млн
81,07 млн
Total operating expenses
127,34 млн
91,00 млн
105,40 млн
105,40 млн
Operating income
8,60 млн
-21,06 млн
-321,50 м.
-321,50 м.
Other non operating income
1,63 млн
978,00 м.
-5,03 млн
-5,03 млн
EBT including unusual items
11,43 млн
-19,69 млн
-8,38 млн
-8,38 млн
EBT excluding unusual items
9,75 млн
-20,60 млн
-4,48 млн
-4,48 млн
Income tax expense
-1,39 млн
-5,65 млн
-3,12 млн
-3,12 млн
Effective tax rate
-12,15%
28,68%
37,29%
37,29%
Other operating expenses
-
-
-
-
Net income
12,82 млн
-14,04 млн
-5,25 млн
-5,25 млн
Net profit margin
9,43%
-20,08%
-5,00%
-5,00%
Earnings per share
-
-
-
-
Interest and investment income
91,00 мың
22,00 мың
2,38 млн
2,38 млн
Interest expense
-567,00 м.
-530,00 м.
-918,50 м.
-918,50 м.
Net interest expenses
-476,00 м.
-508,00 м.
1,47 млн
1,47 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
23,42 млн
-5,75 млн
17,68 млн
17,68 млн
Gain or loss from assets sale
23,00 мың
5,00 мың
1,00 мың
1,00 мың
AI content may include mistakes. Learn more
Google қолданбалары